NCT00003266 2023-06-18
Methylphenidate in Treating Patients With Melanoma
Eastern Cooperative Oncology Group
Phase 3 Completed
Clinical Trials
7 trialsNCT05041946 2022-09-29
Patient Controlled Methylphenidate for Cancer Related Fatigue: A Double Blind, Randomized, Placebo Controlled Trial
M.D. Anderson Cancer Center
Phase 3 Completed
NCT00031798 2021-09-09
Methylphenidate to Improve Quality of Life in Patients Undergoing Radiation Therapy for Brain Tumors
Wake Forest University Health Sciences
Phase 3 Terminated
NCT00418691 2020-09-23
Effects of Methylphenidate Versus Sustained Release Methylphenidate on Cognitive Functioning
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT03218254 2018-12-05
MICRO
Odense University Hospital
Phase 3 Unknown
NCT00516269 2018-01-03
Trial of a Sustained Release Methylphenidate in the Treatment of Fatigue in Cancer Patients
M.D. Anderson Cancer Center
Phase 3 Terminated
NCT00376675 2016-08-01
Methylphenidate in Treating Patients With Fatigue Caused by Cancer
Alliance for Clinical Trials in Oncology
Phase 3 Completed